Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial
- 1 March 2006
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 104 (3), 360-368
- https://doi.org/10.3171/jns.2006.104.3.360
Abstract
The goal of this study was to assess the impact of neuronavigation on the cytoreductive treatment of solitary contrast-enhancing intracerebral tumors and outcomes of this treatment in cases in which neuronavigation was preoperatively judged to be redundant. The authors conducted a prospective randomized study in which 45 patients, each harboring a solitary contrast-enhancing intracerebral tumor, were randomized for surgery with or without neuronavigation. Peri- and postoperative parameters under investigation included the following: duration of the procedure; surgeon's estimate of the usefulness of neuronavigation; quantification of the extent of resection, determined using magnetic resonance imaging; and the postoperative course, as evaluated by neurological examinations, the patient's quality-of-life self-assessment, application of the Barthel index and the Karnofsky Performance Scale score, and the patient's time of death. The mean amount of residual tumor tissue was 28.9% for standard surgery (SS) and 13.8% for surgery involving neuronavigation (SN). The corresponding mean amounts of residual contrast-enhancing tumor tissue were 29.2 and 24.4%, respectively. These differences were not significant. Gross-total removal (GTR) was achieved in five patients who underwent SS and in three who underwent SN. Median survival was significantly shorter in the SN group (5.6 months compared with 9 months, unadjusted hazard ratio = 1.6); however, this difference may be attributable to the coincidental early death of three patients in the SN group. No discernible important effect on the patients' 3-month postoperative course was identified. There is no rationale for the routine use of neuronavigation to improve the extent of tumor resection and prognosis in patients harboring a solitary enhancing intracerebral lesion when neuronavigation is not already deemed advantageous because of the size or location of the lesion.Keywords
This publication has 41 references indexed in Scilit:
- Neuronavigation Combined with Electrophysiological Monitoring for Surgery of Lesions in Eloquent Brain Areas in 42 Cases: A Retrospective Comparison of the Neurological Outcome and the Quality of Resection with a Control Group with Similar Lesionsmin - Minimally Invasive Neurosurgery, 2003
- Quantification of, Visualization of, and Compensation for Brain Shift Using Intraoperative Magnetic Resonance ImagingNeurosurgery, 2000
- High-grade Astrocytomas in Children: Radiologically Complete Resection Is Associated with an Excellent Long-term PrognosisNeurosurgery, 1996
- Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomasCancer, 1995
- Long-term follow-up results of 175 patients with malignant glioma: Importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiationActa Neurochirurgica, 1994
- Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma: Objective Evaluation of Residual Tumor and Its Influence on Regrowth and PrognosisNeurosurgery, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Open Surgery Assisted by the Neuronavigator, a Stereotactic, Articulated, Sensitive ArmNeurosurgery, 1991
- Three-dimensional digitizer (neuronavigator): New equipment for computed tomography-guided stereotaxic surgerySurgical Neurology, 1987
- A frameless stereotaxic integration of computerized tomographic imaging and the operating microscopeJournal of Neurosurgery, 1986